Stryker Names Ortho and Neuro Group Presidents

Kalamazoo, Mich.-based Stryker Corp. has appointed a new group president to lead its orthopedics business. David Floyd assumed the position on Nov. 15.

Orthopedics includes the company’s reconstructive, trauma and extremities, joint preservation, orthobiologics, and performance solutions businesses. Floyd will report directly to Kevin Lobo, president and CEO of Stryker.

Floyd joins Stryker after 25 years in the medical technology and orthopedics industry where he held a number of senior level leadership roles at Johnson & Johnson’s DePuy, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics, and most recently as CEO for OrthoWorx.

Stryker also announced a management realignment that take effect on Jan. 1. Floyd be responsible for Stryker’s spine business, and Timothy Scannell will oversee Stryker’s neurotechnology businesses, including the neurovascular unit and craniomaxillofacial business.

As group president of MedSurg and Neurotechnology, Scannell will continue to report to Lobo and maintain responsibility for the Instruments, Medical, Endoscopy, and Sustainability Solutions divisions.

Scannell began his career with Stryker in 1990 and held various leadership positions within the Endoscopy, Biotech, and Spine divisions before being named group president in 2008. He currently serves as group president of MedSurg and Spine.

“David brings a strong medical device and orthopedic perspective to Stryker through his successful leadership roles in a broad range of enterprises, including a venture backed startup, middle market med tech and large cap multinationals,” said Lobo. “He is a proven leader who has demonstrated the ability to drive profitable growth through innovation and we are delighted to have David join our executive team at Stryker. Floyd has successfully managed global businesses through unprecedented industry change while maintaining strong company, regulatory and customer relationships.”